We are pleased to announce that Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions from 5th to 8th September in Chicago, Illinois.

This event, hosted by the American Heart Association, brings together leading experts to discuss the latest research and advancements in hypertension.

The conference features oral and poster presentations, panel discussions, and sessions tailored for clinicians, researchers, and primary care providers.

To connect with Dr. Taubel during the event, please reach out to arrange a meeting.

Tofind out more, click here.

Latest news

Richmond Pharmacology highlights encouraging first-in-human results for Regeneron's investigational RNAi therapy in MASLD

November 12, 2026
NEJM publication and AASLD presentation reports that 79% of treated participants with MASLD and available measurements achieved normal liver fat levels at Week 24 after a single dose of CIDEBsiRNA, alongside improvements in markers of liver injury.
Read more

Upcoming Event

AHA Scientific Sessions 2026

14 - 16 November 2026
Richmond Pharmacology is excited to join the AHA Scientific Sessions 2026 in 14–16 November 2026, on 14–16 November 2026, hosted by the American Heart Association.
View event